These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11702746)

  • 41. Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus.
    Tsurumaru M; Kajiyama Y; Udagawa H; Akiyama H
    Ann Thorac Cardiovasc Surg; 2001 Dec; 7(6):325-9. PubMed ID: 11888470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection.
    Igaki H; Kato H; Tachimori Y; Nakanishi Y
    Surgery; 2003 Apr; 133(4):368-74. PubMed ID: 12717353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics of lymph node metastasis of squamous cell carcinoma of thoracic esophagus and its clinical significance].
    Wang Y; Wang L; Zhang D
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):241-3. PubMed ID: 11778241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endoscopic mucosal resection as curative therapy for esophageal cancer is inappropriate and should be discouraged.
    von Rahden BH; Stein HJ
    Endoscopy; 2008 Feb; 40(2):169; author reply 170. PubMed ID: 18253913
    [No Abstract]   [Full Text] [Related]  

  • 45. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
    J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Selective three-field lymphadenectomy for thoracic esophageal squamous carcinoma].
    Fang WT; Chen WH; Chen Y; Shen YZ; Jiang Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):388-91. PubMed ID: 17043956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does the TNM staging system for esophageal cancer need revision?
    Pramesh CS; Mistry RC; Jambhekar NA; Laskar SG
    J Am Coll Surg; 2006 May; 202(5):855-6; author reply 856. PubMed ID: 16648030
    [No Abstract]   [Full Text] [Related]  

  • 48. Tumor cell dissociation score highly correlates with lymph node metastasis in superficial esophageal carcinoma.
    Chibana Y; Fujii S; Ichikawa K; Fujita M; Ono Y; Tomita S; Imura J; Kawamata H; Terano A; Fujimori T
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1371-8. PubMed ID: 16105123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic factors in patients with submucosal esophageal cancer.
    Natsugoe S; Matsumoto M; Okumura H; Ikeda M; Ishigami S; Owaki T; Takao S; Aikou T
    J Gastrointest Surg; 2004; 8(5):631-5. PubMed ID: 15240002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
    Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
    Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A strategy for determining which thoracic esophageal cancer patients should undergo cervical lymph node dissection.
    Nagatani S; Shimada Y; Kondo M; Kaganoi J; Maeda M; Watanabe G; Imamura M
    Ann Thorac Surg; 2005 Nov; 80(5):1881-6. PubMed ID: 16242473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
    Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
    Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemically detected micrometastasis in lymph nodes from superficial esophageal squamous cell carcinoma.
    Tanabe T; Nishimaki T; Watanabe H; Ajioka Y; Akazawa K; Komukai S; Hatakeyama K
    J Surg Oncol; 2003 Mar; 82(3):153-9. PubMed ID: 12619058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus.
    Metzger R; Drebber U; Baldus SE; Mönig SP; Hölscher AH; Bollschweiler E
    Ann Surg Oncol; 2009 Feb; 16(2):447-53. PubMed ID: 19037700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Characteristics of lymph node metastasis in thoracic esophageal carcinoma].
    Li JD; Wang WG; Xu JL; Gao ZR; Shao LF
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3197-200. PubMed ID: 17313786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma.
    Sako A; Kitayama J; Kaisaki S; Nagawa H
    Cancer Lett; 2004 May; 208(1):43-9. PubMed ID: 15105044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.
    Kato K; Hida Y; Miyamoto M; Hashida H; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
    Cancer; 2002 Feb; 94(4):929-33. PubMed ID: 11920460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
    Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T
    J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus.
    Osugi H; Takemura M; Higashino M; Takada N; Lee S; Ueno M; Tanaka Y; Fukuhara K; Hashimoto Y; Fujiwara Y; Kinoshita H
    Oncol Rep; 2003; 10(1):81-7. PubMed ID: 12469149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.